EANM practice guideline for quantitative SPECT-CT
- PMID: 36469107
- PMCID: PMC9931838
- DOI: 10.1007/s00259-022-06028-9
EANM practice guideline for quantitative SPECT-CT
Abstract
Purpose: Quantitative SPECT-CT is a modality of growing importance with initial developments in post radionuclide therapy dosimetry, and more recent expansion into bone, cardiac and brain imaging together with the concept of theranostics more generally. The aim of this document is to provide guidelines for nuclear medicine departments setting up and developing their quantitative SPECT-CT service with guidance on protocols, harmonisation and clinical use cases.
Methods: These practice guidelines were written by members of the European Association of Nuclear Medicine Physics, Dosimetry, Oncology and Bone committees representing the current major stakeholders in Quantitative SPECT-CT. The guidelines have also been reviewed and approved by all EANM committees and have been endorsed by the European Association of Nuclear Medicine.
Conclusion: The present practice guidelines will help practitioners, scientists and researchers perform high-quality quantitative SPECT-CT and will provide a framework for the continuing development of quantitative SPECT-CT as an established modality.
Keywords: Bone; Cardiology; Dosimetry; Neurology; Quantification; SPECT-CT.
© 2022. The Author(s).
Conflict of interest statement
AKK is a full-time employee at Scanomed Nuclear Medicine Center Debrecen, Hungary, a subsidiary company of Mediso Medical Imaging Systems, Budapest, Hungary. KH reports personal fees from Bayer, personal fees and other from Sofie Biosciences, personal fees from SIRTEX, non-financial support from ABX, personal fees from Adacap, personal fees from Curium, personal fees from Endocyte, grants and personal fees from BTG, personal fees from IPSEN, personal fees from Siemens Healthineers, personal fees from GE Healthcare, personal fees from Amgen, personal fees from Novartis, personal fees from ymabs, all outside the submitted work. JCD, ISA, PMG, AMD-B, JG, TvdW and L-FdG-O all declare that they do not have any conflicts of interest.
Figures
References
-
- Capoccetti F, Biggi E, Rossi G, Manni C, Brianzoni E. Differentiated thyroid carcinoma: diagnosis and dosimetry using 124I PET/CT. Clin Transl Imaging. 2013;1(3):185–193. doi: 10.1007/s40336-013-0021-3. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
